SCALABLE MANUFACTURING OF CAR-T CELLS USING A NON -VIRAL APPROACH AND A TRANSPOSON-TRANSPOSASE SYSTEM

被引：0
|
作者：
Couto, P. Silva [1 ]
Stibbs, D. [1 ]
Springuel, P. [2 ]
Rafiq, Q. A. [3 ]
机构：
[1] UCL, Biochem Engn, London, England
[2] UCL, Dept Biochem Engn, London, England
[3] UCL, Dept Biochem Engn, London, England
来源：
CYTOTHERAPY | 2024年 / 26卷 / 06期
关键词：
CAR-T; manufacturing; electroporation;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1002
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [1] Transposon Mediated CAR-T Cell Manufacturing Using Scalable Electroporation of Resting PBMCs or Activated T Cells
    Heine, Peer
    Shivakumar, Rama
    Gee, Peter
    Acharya, Diwash
    Khoruzhenko, Stanislav
    Brady, James
    MOLECULAR THERAPY, 2020, 28 (04) : 331 - 332
  • [2] Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System
    Costello, Caitlin
    Derman, Ben A.
    Kocoglu, Mehmet Hakan
    Deo, Abhinav
    Ali, Abbas Abbas
    Gregory, Tara
    Dholaria, Bhagirathbhai
    Berdeja, Jesus G.
    Cohen, Adam D.
    Patel, Krina K.
    Siegel, David S.
    Nath, Rajneesh
    McArthur, Katherine
    McCaigue, Joanne
    Martin, Christopher E.
    Ghoddusi, Majid
    Namini, Hamid
    Ostertag, Eric M.
    Spear, Matthew A.
    Belani, Rajesh
    Shah, Nina
    BLOOD, 2021, 138 : 3858 - +
  • [3] Harnessing Multivalent CAR-T Cells and piggyBac Transposon-based manufacturing system for Solid Tumor
    Yagyu, Shigeki
    CANCER SCIENCE, 2025, 116 : 1787 - 1787
  • [4] SCALABLE, ROBUST AND COST EFFECTIVE CAR-T MANUFACTURING
    Schweickart, R.
    CYTOTHERAPY, 2019, 21 (05) : S44 - S44
  • [5] Evolution of a Hyperactive TcBuster Transposase Enables Highly Efficient Non-Viral Generation of CAR-NK and CAR-T Cells for Combination Cell Therapies
    Skeate, Joseph G.
    Pomeroy, Emily
    Jones, Bryan
    Slipek, Nicholas
    Wick, Bryce
    Lahr, Walker
    Stelljes, Erin
    Patrinostro, Xiaobai
    Barnes, Blake
    Zarecki, Trevor
    Krueger, Joshua
    Bridge, Jacob
    Robbins, Gabrielle
    McCormick, Madeline
    Largaespada, David A.
    Otto, Neil
    Webber, Beau R.
    Moriarity, Branden S.
    MOLECULAR THERAPY, 2023, 31 (04) : 177 - 178
  • [6] Non-Viral Engineering of CAR-NK Cells Using the TC Buster Transposon System™
    Pomeroy, Emily J.
    Lahr, Walker S.
    Webber, Beau R.
    Moriarity, Branden S.
    MOLECULAR THERAPY, 2021, 29 (04) : 72 - 73
  • [7] Current Non-Viral-Based Strategies to Manufacture CAR-T Cells
    Gehrke, Leon
    Goncalves, Vasco Dos Reis
    Andrae, Dominik
    Rasko, Tamas
    Ho, Patrick
    Einsele, Hermann
    Hudecek, Michael
    Friedel, Sabrina R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)
  • [8] QUALIFIABLE POTENCY ASSAY FOR CAR-T CELLS USING TWO SCALABLE PLATFORMS
    Kandell, J.
    Sylakowski, K.
    Lakshmipathy, U.
    CYTOTHERAPY, 2024, 26 (06) : S178 - S179
  • [9] Generation of Human CAR-T Cells Using the Solupore Non-Viral Cell Engineering Platform
    Kavanagh, Heather
    Dunne, Susan
    McFadden, Emily
    O'Dea, Shirley
    MOLECULAR THERAPY, 2020, 28 (04) : 478 - 478
  • [10] Optimization of lymphapheresis for manufacturing autologous CAR-T cells
    Ikumi Yamanaka
    Takuji Yamauchi
    Tomoko Henzan
    Teppei Sakoda
    Kyoko Miyamoto
    Hiroyuki Mishima
    Hiroaki Ono
    Yuhki Koga
    Yasuhiro Nakashima
    Koji Kato
    Toshihiro Miyamoto
    Shinichi Mizuno
    Yoshihiro Ogawa
    Shouichi Ohga
    Koichi Akashi
    Takahiro Maeda
    Yuya Kunisaki
    International Journal of Hematology, 2021, 114 : 449 - 458
12345